CROSS COUNTRY HEALTHCARE INC (CCRN) Stock Fundamental Analysis

NASDAQ:CCRN • US2274831047

8.08 USD
+0.13 (+1.64%)
At close: Feb 13, 2026
8.08 USD
0 (0%)
After Hours: 2/13/2026, 8:00:02 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to CCRN. CCRN was compared to 102 industry peers in the Health Care Providers & Services industry. CCRN is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. CCRN has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • CCRN had positive earnings in the past year.
  • CCRN had a positive operating cash flow in the past year.
  • In multiple years CCRN reported negative net income over the last 5 years.
  • CCRN had a positive operating cash flow in 4 of the past 5 years.
CCRN Yearly Net Income VS EBIT VS OCF VS FCFCCRN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -2.91%, CCRN is doing worse than 62.75% of the companies in the same industry.
  • CCRN's Return On Equity of -3.84% is in line compared to the rest of the industry. CCRN outperforms 46.08% of its industry peers.
  • CCRN has a Return On Invested Capital (0.98%) which is comparable to the rest of the industry.
  • CCRN had an Average Return On Invested Capital over the past 3 years of 15.05%. This is significantly above the industry average of 8.97%.
  • The 3 year average ROIC (15.05%) for CCRN is well above the current ROIC(0.98%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA -2.91%
ROE -3.84%
ROIC 0.98%
ROA(3y)9.37%
ROA(5y)8.5%
ROE(3y)17.7%
ROE(5y)17.81%
ROIC(3y)15.05%
ROIC(5y)13.58%
CCRN Yearly ROA, ROE, ROICCCRN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

1.3 Margins

  • CCRN has a Operating Margin (0.56%) which is in line with its industry peers.
  • In the last couple of years the Operating Margin of CCRN has declined.
  • CCRN's Gross Margin of 20.19% is in line compared to the rest of the industry. CCRN outperforms 44.12% of its industry peers.
  • CCRN's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 0.56%
PM (TTM) N/A
GM 20.19%
OM growth 3Y-77.97%
OM growth 5Y-33.84%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.01%
GM growth 5Y-3.83%
CCRN Yearly Profit, Operating, Gross MarginsCCRN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CCRN is creating some value.
  • The number of shares outstanding for CCRN has been reduced compared to 1 year ago.
  • The number of shares outstanding for CCRN has been reduced compared to 5 years ago.
  • There is no outstanding debt for CCRN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CCRN Yearly Shares OutstandingCCRN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
CCRN Yearly Total Debt VS Total AssetsCCRN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

  • CCRN has an Altman-Z score of 4.36. This indicates that CCRN is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 4.36, CCRN is in the better half of the industry, outperforming 78.43% of the companies in the same industry.
  • There is no outstanding debt for CCRN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 4.36
ROIC/WACC0.11
WACC8.68%
CCRN Yearly LT Debt VS Equity VS FCFCCRN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

  • CCRN has a Current Ratio of 3.45. This indicates that CCRN is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 3.45, CCRN belongs to the top of the industry, outperforming 85.29% of the companies in the same industry.
  • A Quick Ratio of 3.45 indicates that CCRN has no problem at all paying its short term obligations.
  • With an excellent Quick ratio value of 3.45, CCRN belongs to the best of the industry, outperforming 87.25% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.45
Quick Ratio 3.45
CCRN Yearly Current Assets VS Current LiabilitesCCRN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • The earnings per share for CCRN have decreased strongly by -82.86% in the last year.
  • Measured over the past years, CCRN shows a very strong growth in Earnings Per Share. The EPS has been growing by 24.57% on average per year.
  • The Revenue for CCRN has decreased by -22.14% in the past year. This is quite bad
  • The Revenue has been growing by 10.33% on average over the past years. This is quite good.
EPS 1Y (TTM)-82.86%
EPS 3Y-47.22%
EPS 5Y24.57%
EPS Q2Q%-75%
Revenue 1Y (TTM)-22.14%
Revenue growth 3Y-7.11%
Revenue growth 5Y10.33%
Sales Q2Q%-20.65%

3.2 Future

  • CCRN is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -33.46% yearly.
  • Based on estimates for the next years, CCRN will show a decrease in Revenue. The Revenue will decrease by -7.58% on average per year.
EPS Next Y-76.58%
EPS Next 2Y-48.21%
EPS Next 3Y-33.46%
EPS Next 5YN/A
Revenue Next Year-20.04%
Revenue Next 2Y-13.03%
Revenue Next 3Y-7.58%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CCRN Yearly Revenue VS EstimatesCCRN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B 2.5B
CCRN Yearly EPS VS EstimatesCCRN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4 5

More info and screens

Find the best growth stocksShow best growing peers

3

4. Valuation

4.1 Price/Earnings Ratio

  • CCRN is valuated quite expensively with a Price/Earnings ratio of 67.33.
  • The rest of the industry has a similar Price/Earnings ratio as CCRN.
  • Compared to an average S&P500 Price/Earnings ratio of 26.68, CCRN is valued quite expensively.
  • Based on the Price/Forward Earnings ratio of 66.94, the valuation of CCRN can be described as expensive.
  • CCRN's Price/Forward Earnings ratio is in line with the industry average.
  • When comparing the Price/Forward Earnings ratio of CCRN to the average of the S&P500 Index (28.06), we can say CCRN is valued expensively.
Industry RankSector Rank
PE 67.33
Fwd PE 66.94
CCRN Price Earnings VS Forward Price EarningsCCRN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, CCRN is valued cheaply inside the industry as 84.31% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, CCRN is valued cheaper than 94.12% of the companies in the same industry.
Industry RankSector Rank
P/FCF 5.8
EV/EBITDA 7.01
CCRN Per share dataCCRN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • CCRN's earnings are expected to decrease with -33.46% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)2.74
EPS Next 2Y-48.21%
EPS Next 3Y-33.46%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for CCRN!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CROSS COUNTRY HEALTHCARE INC

NASDAQ:CCRN (2/13/2026, 8:00:02 PM)

After market: 8.08 0 (0%)

8.08

+0.13 (+1.64%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-12
Earnings (Next)03-04
Inst Owners96.15%
Inst Owner Change-88.28%
Ins Owners6.14%
Ins Owner Change11.6%
Market Cap264.70M
Revenue(TTM)1.13B
Net Income(TTM)-15.68M
Analysts71.43
Price Target11.68 (44.55%)
Short Float %4.08%
Short Ratio1.32
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-69.09%
Min EPS beat(2)-118.38%
Max EPS beat(2)-19.79%
EPS beat(4)1
Avg EPS beat(4)-49.67%
Min EPS beat(4)-118.38%
Max EPS beat(4)5.59%
EPS beat(8)4
Avg EPS beat(8)-23.71%
EPS beat(12)7
Avg EPS beat(12)-12.92%
EPS beat(16)11
Avg EPS beat(16)-6.6%
Revenue beat(2)0
Avg Revenue beat(2)-8.46%
Min Revenue beat(2)-9.46%
Max Revenue beat(2)-7.46%
Revenue beat(4)0
Avg Revenue beat(4)-5.87%
Min Revenue beat(4)-9.46%
Max Revenue beat(4)-0.73%
Revenue beat(8)1
Avg Revenue beat(8)-3.08%
Revenue beat(12)3
Avg Revenue beat(12)-1.76%
Revenue beat(16)6
Avg Revenue beat(16)-0.91%
PT rev (1m)0%
PT rev (3m)-36.67%
EPS NQ rev (1m)-1.41%
EPS NQ rev (3m)-36.4%
EPS NY rev (1m)0%
EPS NY rev (3m)-26.19%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-8.55%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-4.04%
Valuation
Industry RankSector Rank
PE 67.33
Fwd PE 66.94
P/S 0.23
P/FCF 5.8
P/OCF 4.88
P/B 0.65
P/tB 1.11
EV/EBITDA 7.01
EPS(TTM)0.12
EY1.49%
EPS(NY)0.12
Fwd EY1.49%
FCF(TTM)1.39
FCFY17.25%
OCF(TTM)1.66
OCFY20.49%
SpS34.42
BVpS12.46
TBVpS7.25
PEG (NY)N/A
PEG (5Y)2.74
Graham Number5.8
Profitability
Industry RankSector Rank
ROA -2.91%
ROE -3.84%
ROCE 1.39%
ROIC 0.98%
ROICexc 1.26%
ROICexgc 2.43%
OM 0.56%
PM (TTM) N/A
GM 20.19%
FCFM 4.05%
ROA(3y)9.37%
ROA(5y)8.5%
ROE(3y)17.7%
ROE(5y)17.81%
ROIC(3y)15.05%
ROIC(5y)13.58%
ROICexc(3y)15.28%
ROICexc(5y)13.73%
ROICexgc(3y)22.9%
ROICexgc(5y)20.79%
ROCE(3y)21.31%
ROCE(5y)19.23%
ROICexgc growth 3Y-75.41%
ROICexgc growth 5Y-32.32%
ROICexc growth 3Y-77.25%
ROICexc growth 5Y-30.83%
OM growth 3Y-77.97%
OM growth 5Y-33.84%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.01%
GM growth 5Y-3.83%
F-Score5
Asset Turnover2.09
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 49.56%
Cap/Sales 0.76%
Interest Coverage 250
Cash Conversion 229.81%
Profit Quality N/A
Current Ratio 3.45
Quick Ratio 3.45
Altman-Z 4.36
F-Score5
WACC8.68%
ROIC/WACC0.11
Cap/Depr(3y)64.63%
Cap/Depr(5y)60.57%
Cap/Sales(3y)0.55%
Cap/Sales(5y)0.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-82.86%
EPS 3Y-47.22%
EPS 5Y24.57%
EPS Q2Q%-75%
EPS Next Y-76.58%
EPS Next 2Y-48.21%
EPS Next 3Y-33.46%
EPS Next 5YN/A
Revenue 1Y (TTM)-22.14%
Revenue growth 3Y-7.11%
Revenue growth 5Y10.33%
Sales Q2Q%-20.65%
Revenue Next Year-20.04%
Revenue Next 2Y-13.03%
Revenue Next 3Y-7.58%
Revenue Next 5YN/A
EBIT growth 1Y-52.34%
EBIT growth 3Y-79.54%
EBIT growth 5Y-27.01%
EBIT Next Year494.68%
EBIT Next 3Y80.04%
EBIT Next 5YN/A
FCF growth 1Y-79.94%
FCF growth 3YN/A
FCF growth 5Y112.02%
OCF growth 1Y-77.47%
OCF growth 3YN/A
OCF growth 5Y85.29%

CROSS COUNTRY HEALTHCARE INC / CCRN FAQ

What is the ChartMill fundamental rating of CROSS COUNTRY HEALTHCARE INC (CCRN) stock?

ChartMill assigns a fundamental rating of 5 / 10 to CCRN.


What is the valuation status for CCRN stock?

ChartMill assigns a valuation rating of 3 / 10 to CROSS COUNTRY HEALTHCARE INC (CCRN). This can be considered as Overvalued.


Can you provide the profitability details for CROSS COUNTRY HEALTHCARE INC?

CROSS COUNTRY HEALTHCARE INC (CCRN) has a profitability rating of 4 / 10.


Can you provide the expected EPS growth for CCRN stock?

The Earnings per Share (EPS) of CROSS COUNTRY HEALTHCARE INC (CCRN) is expected to decline by -76.58% in the next year.